DEGREES PHARMACEUTICALS

We apply the same passion, energy, and culture of innovation that allowed the successful approval of ARAKODA® (tafenoquine) to making a difference in the world. We are committed to finding the tools and strategies that will help us overcome some of the planet's greatest health challenges... Our core business is delivering infectious disease drug development and commercialization while providing an attractive ROI... 60P has embraced an open innovation approach to reduce the time, cost, and risk needed to build a portfolio of drug discovery and development projects. We collaborate with leading research institutions to discover and develop medicines for infectious diseases.

Also known as: Degrees Pharmaceuticals, Inc

Primary location: Washington United States